Načítá se...
Therapy for metastatic pancreatic neuroendocrine tumors
BACKGROUND: Pancreatic neuroendocrine tumors (pNETs) are frequently malignant (50-80%, except for insulinoma) and may show an aggressive course with metastases to the liver as well as more distant sites. These heterogeneous neoplasms include functioning tumors, which secrete a variety of peptide hor...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4200651/ https://ncbi.nlm.nih.gov/pubmed/25332984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2305-5839.2013.03.01 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|